高级检索
当前位置: 首页 > 详情页

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP) ◇ 自然指数

机构: [1]Jilin Canc Hosp, Changchun, Peoples R China [2]Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China [3]Shanghai Pulm Hosp, Shanghai, Peoples R China [4]Sichuan Canc Hosp & Inst, Chengdu, Peoples R China [5]Henan Canc Hosp, Zhengzhou, Peoples R China [6]Anhui Chest Hosp, Hefei, Peoples R China [7]Harbin Med Univ Canc Hosp, Harbin, Peoples R China [8]Northern Jiangsu Peoples Hosp, Yangzhou, Jiangsu, Peoples R China [9]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China [10]Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China [11]Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou, Peoples R China [12]Yunnan Canc Hosp, Kunming, Yunnan, Peoples R China [13]WeiFang Peoples Hosp, Weifang, Peoples R China [14]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [15]Beijing Canc Hosp, Beijing, Peoples R China [16]Zhejiang Canc Hosp, Hangzhou, Peoples R China [17]Affiliated Hosp Jiangnan Univ, Wuxi, Jiangsu, Peoples R China [18]Anhui Prov Hosp, Hefei, Peoples R China [19]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [20]First Hosp China Med Univ, Shenyang, Peoples R China [21]Liaoning Canc Hosp & Inst, Shenyang, Peoples R China [22]Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China [23]Fujian Prov Canc Hosp, Fuzhou, Peoples R China [24]Jiangsu Prov Hosp, Nanjing, Peoples R China [25]Shanghai Chest Hosp, Shanghai, Peoples R China [26]Chongqing Canc Hosp, Chongqing, Peoples R China [27]Xiangya Hosp Cent South Univ, Changsha, Peoples R China [28]Guangxi Med Univ Affiliated Tumor Hosp, Nanning, Peoples R China [29]Guangzhou Med Univ, Ctr Canc, Guangzhou, Peoples R China [30]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China [31]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China [32]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China [33]Fourth Hosp Hebei Med Univ, Shijiazhuang, Hebei, Peoples R China [34]940th Hosp Joint Logist Support Force Peoples Lib, Lanzhou, Peoples R China [35]Qilu Hosp Shandong Univ, Jinan, Peoples R China [36]Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China [37]Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China [38]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
出处:
ISSN:
语种:
WOS:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2022]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Jilin Canc Hosp, Changchun, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43373 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号